GlassScriptPhysician profile
Bradley S Guill
NPI 1942277827
$2,005.72
in general payments reported to CMS, 2019-2025
12 companies · $771 in 2025
The $771 reported for 2025 was more than what 81% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $464 · 2020: $255 · 2021: $156 · 2022: $194 · 2024: $166 · 2025: $771.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $910 · Education: $27.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $909.93 |
| Education | $27.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $764.94 | 2019-2025 | Ozempic, Rybelsus |
| Abbott Laboratories | $396.55 | 2021-2025 | Freestyle Libre 3 |
| Corcept Therapeutics | $260.23 | 2019-2025 | Korlym |
| Amgen INC. | $133.59 | 2020-2025 | |
| Daiichi Sankyo INC. | $124.46 | 2024 | Enhertu |
| Astrazeneca Pharmaceuticals LP | $106.89 | 2020 | |
| Tandem Diabetes Care, INC. | $103.67 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Medtronic, INC. | $37.39 | 2021-2025 | Minimed 780g |
| Otsuka America Pharmaceutical, INC. | $27.34 | 2024 | Rexulti |
| Lilly USA, LLC | $27.14 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $12.45 | 2019 | |
| Merck Sharp & Dohme LLC | $11.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley Guill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.